Abstractive Health vs Zus Health
Both start from the same insight, that the record worth summarising is not the one in front of you, and then they build different things on it. Zus assembles the longitudinal record: data from thousands of provider sites through the national networks, prescription fills, admission and discharge alerts, deduplicated and normalised, covering more than 320 million patients, with a published matching success rate of roughly 90 percent and the most detailed consent architecture in this index. Abstractive Health summarises that record and links every sentence back to the note it came from, and it published its own evaluation in a peer reviewed journal with a result that made its product look worse than physicians. Buy Zus if the problem is that the data is scattered. Buy Abstractive if the problem is that nobody can read what you already have.
- It published its own evaluation in a peer reviewed journal and the headline result was unfavourable to itself, finding its summaries marginally inferior to physicians on usefulness and safety. That is the strongest governance signal a vendor in this category can send.
- Verification is at sentence level. Every sentence of a summary links back to the source note it came from, which makes checking a specific claim a single action rather than a hunt through a reassembled record.
- The compliance position is complete rather than partial: SOC 2 Type II claimed for the company itself, a live public trust centre, a published business associate agreement and a published commercial ladder with real figures including a free tier.
- It is infrastructure rather than an application, so the assembled record can feed anything you build. Data arrives from thousands of provider sites through the national networks, prescription fills through Surescripts and admission and discharge alerts through named partners, then deduplicated and normalised to a common standard.
- The consent architecture is described in more detail than almost anything else in this index, gating access to third party data on the customer asserting an active treatment relationship rather than on an unspecified permission.
- It publishes a matching success rate of roughly 90 percent, which is an explicit admission that identity resolution is imperfect, and it links every summarised point directly to the underlying record.
Side by Side
| Axis | A Abstractive Health |
Z Zus Health |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Summarization & Chart Review page.
These sit at different layers and can be complementary rather than exclusive: one assembles and normalises the record, the other summarises it with sentence level provenance. Zus publishes no security attestation and no trust centre across two passes, which is unusually consequential for a platform whose central design property is cross tenant data sharing, and it offers no customer hosted or single tenant option because the architecture is incompatible with one.
Zus publishes no pricing or pricing mechanism. Abstractive Health has named itself into a regulatory category it has not addressed: no clearance, device authorisation, pathway statement or exemption analysis was located.